← Browse by Condition
Medical Condition

pre eclampsia

Total Trials
8
Recruiting Now
8
Trial Phases
Phase 3

ClinicalMetric tracks all active clinical trials for pre eclampsia sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — pre eclampsia Clinical Trials

How many clinical trials are currently recruiting for pre eclampsia?
ClinicalMetric currently tracks 8 actively recruiting clinical trials for pre eclampsia, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 8. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for pre eclampsia?
pre eclampsia research spans Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a pre eclampsia clinical trial?
Eligibility criteria for pre eclampsia trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 3
1
Top Sponsors
University Hospital, Toulouse 1 trial
Oulu University Hospital 1 trial
Withings 1 trial
St. Olavs Hospital 1 trial
Maastricht University Medical Center 1 trial

Recruiting Clinical Trials

NCT05625724 Phase 3
Recruiting
Aspirin for the Prevention of Preeclampsia and Pregnancy Outcomes After Assisted Reproductive Technology
Enrollment
1,164 pts
Location
France
Sponsor
University Hospital, Toulouse
View Trial →
NCT06115122
Recruiting
PEPPI Study: Identification of Women at Risk for Placental Dysfunction
Enrollment
3,000 pts
Location
Finland
Sponsor
Oulu University Hospital
View Trial →
NCT07595016
Recruiting
Clinical Validation of the Blood Pressure Measuring Device Withings BPM Pro 2 in Pregnancy and Pre-Eclampsia
Enrollment
45 pts
Location
Armenia
Sponsor
Withings
View Trial →
NCT06108947
Recruiting
Screening for Preeclampsia in Norway With Aspirin Discontinuation at 24-28 Weeks
Enrollment
300 pts
Location
Norway
Sponsor
St. Olavs Hospital
View Trial →
NCT05500989
Recruiting
PlacEntal Acute Atherosis RefLecting Subclinical Atherosclerosis
Enrollment
226 pts
Location
Netherlands
Sponsor
Maastricht University Medical ...
View Trial →
NCT06319014
Recruiting
Physical Activity to Mitigate PreEclampsia Risk
Enrollment
224 pts
Location
United States
Sponsor
East Carolina University
View Trial →
NCT06317467
Recruiting
Role of Anti-C1q Autoantibodies in Pregnancy
Enrollment
54 pts
Location
Italy
Sponsor
IRCCS Burlo Garofolo
View Trial →
NCT07245056
Recruiting
Fetal Fornix and Hippocampus in Pregnant Women With Early-Onset Preeclampsia
Enrollment
84 pts
Location
Turkey (Türkiye)
Sponsor
Ankara Etlik City Hospital
View Trial →

Related Conditions

intrauterine growth restriction (2) art (1) polycystic ovary syndrome (1) iron deficiency (1) cardiovascular diseases (1) hypertensive disorder of pregnancy (1) proteinuria in pregnancy (1) hypertension (1) hellp syndrome (1) pregnancy (1) hippocampus (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology